PharmaFocus Today – Page 383 – media

Russia approves a second vaccine

Last month, Russia announced the approval of a COVID-19 vaccine called Sputnik V. This week, President Vladimir Putin announced the approval of a second vaccine, called EpiVacCorona. As with the first, scientists have not yet tested this vaccine in phase 3 trials. The vaccine was developed by scientists at the State Virology and Biotechnology Center, known as Vektor, in Novosibirsk. According to The Moscow Times: “Early trials on 100 volunteers were said to have been successful.” In a televised news conference, Putin explained that researchers had given the vaccine to Deputy Prime Minister Tatyana Golikova and the head of Russia’s consumer safety watchdog, Anna Popova, as part of ongoing trials. During the briefing, they explained that: “Early trials on 100 volunteers were said to have been successful.” As with Sputnik V, experts are likely to view the new vaccine with skepticism. Vaccines must be rigorously investigated before they can be used widely, and ...
- Source: drugdu
- 377
- October 19, 2020
Covid
Moderna coronavirus vaccine shows ‘promising’ safety and immune response results in published Phase 1 study, but more research is needed

(CNN)A Covid-19 vaccine developed by the biotechnology company Moderna in partnership with the National Institutes of Health has been found to induce immune responses in all of the volunteers who received it in a Phase 1 study.
- Source: drugdu
- 453
- July 15, 2020
coronavirus vaccine Covid-19 vaccine
Should Chloroquine Be Used to Treat Covid-19?

As the fight against the Coronavirus rages, the debate surrounding the possible use of chloroquine and a derivative, hydroxychloroquine, is heating up.
- Source: drugdu
- 493
- May 19, 2020
Chloroquine Covid-19 vaccination
AZ’s Farxiga Gets FDA Priority Review For Heart Failure

AstraZeneca has got off to a strong start in 2020, with the FDA granting a fast review for its diabetes drug Farxiga in heart failure and China approving Lokelma for hyperkalemia.
- Source: https://scrip.pharmaintelligence.informa.com/SC141424/AZs-Farxiga-Gets-FDA-Priority-Review-For-Heart-Failure
- 1,401
- January 8, 2020
AstraZeneca Farxiga FDA Lokelma
What ingredients are in vaccines?

Vaccines are a central player in our fight against infectious diseases. What components are commonly found in vaccines, and what is their purpose? In this Special Feature article, we find out. Why do some vaccines have a long list of components? Many people will be familiar with the concept that a vaccine against a particular virus will contain a small amount of the pathogen or a part of it, at least. When we receive the vaccine, the viral interloper triggers our immune system to launch a series of events that leave us protected against the pathogen in the future. But a glance at the ingredients in common vaccines reveals a long list of other components, the roles of which might not seem so clear cut. What is the purpose of the likes of gelatin, thimerosal, and Polysorbate 80? And why do some vaccines contain aluminum? In this Special Feature article, ...
- Source: drugdu
- 887
- December 17, 2019
Ddu College ingredient vaccine
Can the keto diet help beat the flu?

Source： https://www.medicalnewstoday.com/articles/327186.php Results of a new study in mice suggest that the body may be able to defeat the influenza virus if a person has the right sort of diet — a ketogenic, or keto, diet. Infection with the influenza virus, better known as the flu, has accounted for 12,000–61,000Trusted Source deaths every year since 2010 in the United States, with an annual economic burden of $87.1 billionTrusted Source. The introduction of the flu vaccine has greatly improved infection and morbidity rates. However, there is still currently no cure for the illness. Healthcare professionals and scientists alike are continuing the search for novel therapeutics to combat the flu, yet the key may lie within the body’s own immune system. Moreover, it may be activated by the keto diet. Following the keto diet involves eating foods that are high in fat and low in carbohydrates. Meals tend to consist of ...
- Source: drugdu
- 408
- December 12, 2019
Study outlines concerns around natural psychoactive substances

Source : https://www.medicalnewstoday.com/articles/327192.php#1 Medical news today New research finds that over a period of 17 years, people in the United States increased their use of natural psychoactive substances, believing them to be safe. This has led to many reports of adverse symptoms in adults and children alike.People have been using natural psychoactive substances for hundreds or even thousands, of years in traditional medicine and as a part of spiritual practices. Because these substances come from sources such as plants and mushrooms, many people believe them to be safe to use.However, because they interfere with biological processes in the central nervous system, they can be a threat to human health. These interferences can also cause euphoria and altered states of consciousness. The Center for Injury Research and Policy at the Research Institute at Nationwide Children’s Hospital in Columbus, OH, collaborated with the Ohio State University College of Medicine, also in Columbus, to ...
- Source: drugdu
- 258
- December 4, 2019
Genentech Announces Positive Results for First Global Phase III Study Investigating One-dose XOFLUZA (Baloxavir Marboxil) in Children With the Flu

– The MINISTONE-2 study showed XOFLUZA, given as a new oral suspension, is a well-tolerated and effective potential treatment for the flu in otherwise healthy children aged one to less than 12 years – – Approximately one in three children develop the flu every year and they are often contagious longer than adults – treating children may therefore help reduce symptoms and prevent the spread of the flu to the wider community – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Jul. 3, 2019– Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III MINISTONE-2 study met its primary endpoint, demonstrating that XOFLUZA™ (baloxavir marboxil) was well-tolerated in children with the flu. The study also showed that XOFLUZA is comparable to oseltamivir – a proven effective treatment for children with the flu – at reducing the duration of flu symptoms, including fever. The study assessed XOFLUZA versus ...
- Source: drugdu
- 1,360
- August 2, 2019
flu Roche Xofluza
Measles Outbreak Spurs Vaccination Surge in Anti-Vaxxer Hotspot

Weeks after a hotspot for anti-vaxxers turned into a hotspot for measles infections, vaccination rates have surged in the area
- Source: https://www.livescience.com/64728-measles-outbreak-spurs-vaccination.html
- 651
- February 28, 2019
measles vaccination
Zapping tumors in less than a second

Researchers at SLAC and Stanford are developing new accelerator-based technology that aims to speed up cancer radiation therapy by hundreds of times and make related medical devices more compact. The approach could reduce side effects in patients and possibly make radiation therapy more accessible around the world.
- Source: www.sciencedaily.com/releases/2018/11/181130175055.htm
- 573
- December 28, 2018
anti-cancer New-tech

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.